Apr 24, 2018 - Sanofi (NYSE:SNY) Head of Global Research and Development Elias Zerhouni, M.D., will retire effective June 30.John Reed, M.D., Ph.D., former Global Head of Pharma Research & Early Development at R
Apr 23, 2018 - A discussion about the latest justifications for turning around the stalled growth in Afrezza prescriptions.Why false issues will not solve MannKind's problems.I will introduce a simple tracking metho
Apr 20, 2018 - Shire (SHPG) declines Takeda Pharmaceutical's third acquisition offer in a cash-stock deal.
Apr 20, 2018 - Despite the skittish trading behaviors for bioscience stocks in the prior month, we wish to elucidate why this niche is actually ripe for investing.Historical data showed that as a group, bioscience e
Apr 20, 2018 - Wall Street thrives on picking prices for equities. Nearly all my articles include Broker 1yr. Target estimates. This Wall St. Star series was suggested by a reader, Minnesota72. Nationality was. 38 o
Apr 19, 2018 - Sanofi (SNY) announces sale of its European generic unit, Zentiva, for $2.4 billion.
Apr 18, 2018 - ASLAN Pharmaceuticals intends to raise $60 million in a U.S. IPO. The firm is developing a mid- to late-stage pipeline of cancer treatments. Pivotal trials lay ahead, but management has done well with
Apr 18, 2018 - Strong portfolio performance to date +21%.Has achieved primary goals of out-performing the XBI and SPY.Continued catalysts are expected to drive the portfolio higher, and there are many to come - the
Apr 17, 2018 - Top Analyst Reports for AbbVie, Berkshire & PepsiCo
Apr 17, 2018 - Evelo Biosciences has filed to raise $100 million in an IPO although the final amount may be less.The firm is developing drug candidates using the gut-related technologies of monoclonal microbials.Jus